Evolve Your Success
AUGUST 28, 2024
Badia’s transition from group practices to establishing the Badia Hand to Shoulder Center is a tale of perseverance, specialization, and strategic branding. We discussed the challenges he faced when opting for a solo practice model and the importance of fair compensation and specialized outpatient care.
Clarivate
SEPTEMBER 25, 2024
3] Figure 1: The Development of Targeted Treatments for Syphilis Source: Valent P et al, 2016;3 Strebhardt K et al, 2008. [4] At Clarivate, we specialize in developing robust and compelling value communication materials that help our clients achieve their market access goals. 2008 2008/06/01;8(6):473-80. [5] N Engl J Med.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Legacy MEDSearch
APRIL 11, 2023
Chief, Hip and Knee Division of Sports Medicine Institute, Hospital for Special Surgery in New York. We offer special thanks to our study patients and surgeon investigators who helped advance the understanding of this new treatment for OA.
PM360
FEBRUARY 12, 2024
This February we celebrate the 16th annual Rare Disease Day , established in 2008, to raise awareness of the more than 7,000 identified rare diseases worldwide. Rare Disease Day is observed annually on the “rarest” day of the year, February 28th or 29th depending on leap years.
PM360
AUGUST 26, 2024
During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. When once a small population needed a special status called “rare”, now all diseases will be defined by endotypes and phenotypes – smaller segments of like patients with common molecular characteristics.
Nixon Gwilt Law
FEBRUARY 27, 2023
Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.”
European Pharmaceutical Review
FEBRUARY 2, 2023
The last paracetamol plant in Europe, closed in France in 2008 as it was no longer economically sustainable, marking the exit of paracetamol manufacturing from Europe” The closure of API manufacturing plants in Europe started in earnest 15 years ago.
Expert insights. Personalized for you.
52 
Let's personalize your content